Skip to main content
Equibles

Ikarian Capital, LLC

Position in IBIO — iBio, Inc.

CIK 1778253 DALLAS, TX
Back to IBIO Full portfolio

Position in IBIO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,674,858
-$143,559 QoQ
Shares Held
957,062
0.0% QoQ
Ownership
1.49%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#13
of 55 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IBIO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Ikarian Capital, LLC holds $559,861,982 across 103 Biotechnology names. IBIO ranks #60 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 328,635 $43,793,900
2 KOD
Kodiak Sciences Inc.
 1,059,730 $41,287,080
3 ALMS
Alumis Inc.
 870,548 $24,497,220
4 PRAX
Praxis Precision Medicines, Inc.
 72,842 $24,386,773
5 PCVX
Vaxcyte, Inc.
 388,682 $22,594,084
6 CLDX
Celldex Therapeutics, Inc.
 478,500 $17,804,985
7 RCUS
Arcus Biosciences, Inc.
 504,559 $15,555,553
8 RLMD
Relmada Therapeutics, Inc.
 2,148,359 $14,866,644

All Filings in IBIO

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,674,858 957,062
2026-03-31 $1,818,417 957,062
2025-12-31 $1,847,129 957,062
2025-09-30 $512,381 617,327
2025-06-30 $455,933 599,913
2025-03-31 $2,411,650 599,913
2024-12-31 $1,469,786 599,913
2024-09-30 $1,332,000 600,000
2024-06-30 $1,266,000 600,000
2024-03-31 $2,436,000 600,000